Fig 1.
Choroidal thickness measurements.
Left. Measurements were taken at five locations: subfoveal (SF), nasal (N), temporal (T), superior (S) and inferior (I) Right. Sample EDI SD-OCT foveal slice images showing choroidal thickness measurements at SF, N and T locations in a 72 year old woman with CAD (top) and healthy 70 year old woman (bottom). EDI SD-OCT, enhanced depth imaging spectral domain optical coherence tomography; CAD, coronary artery disease.
Table 1.
Baseline characteristics of coronary artery disease study population compared with control population.
Fig 2.
Cardiovascular history in patients with coronary artery disease.
The majority of patients had a history of cardiac stent, angina or MI. Not shown: 0% of patients reported having a cardiac transplant or aneurysm. CAD, coronary artery disease; MI, myocardial infarction; CABG, coronary artery bypass graft; CHF, congestive heart failure; CVA, cerebrovascular accident; TIA, transient ischemic attack; PAD, peripheral artery disease.
Fig 3.
Subfoveal choroidal thickness in coronary artery disease compared to controls.
Mean choroidal thickness at all 5 macular locations was lower in patients with coronary artery disease (red squares) than controls (blue squares). Average choroidal thickness was greatest at the subfoveal, inferior, and superior locations in both groups. Error bars represent standard deviation. SF, subfoveal; N, nasal; T, temporal; I, inferior.
Table 2.
Subfoveal choroidal thickness and choroidal thickness at 4 cardinal macular locations in the left eye.
All 5 locations showed significantly decreased CTh in patients with coronary artery disease compared with controls.
Table 3.
Pattern of choroidal thickness in eyes of patients with coronary artery disease, showing significantly decreased CTh in the nasal and temporal locations compared with the subfoveal location, consistent with the pattern observed in control eyes.